Search Count: 14
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2018-04-04 Classification: HYDROLASE Ligands: 9CH |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2018-01-31 Classification: HYDROLASE Ligands: 958 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-04-16 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 2GD, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-04-16 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 2GE, SO4 |
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: WM9 |
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: 2FB |
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: DMS, 54M |
 |
Aminoimidazoles As Bace-1 Inhibitors: From De Novo Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2013-06-26 Classification: HYDROLASE Ligands: KGG |
 |
Design And Synthesis Of Bace1 Inhibitors With In Vivo Brain Reduction Of Beta-Amyloid Peptides (Compound 10)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2012-10-17 Classification: HYDROLASE Ligands: ACT, NA, 7F3 |
 |
Design And Synthesis Of Bace1 Inhibitors With In Vivo Brain Reduction Of Beta-Amyloid Peptides (Compound (R)-41)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2012-10-17 Classification: HYDROLASE Ligands: ACT, I6X |
 |
Preclinical Characterization Of Azd3839, A Novel Clinical Candidate Bace1 Inhibitor For The Treatment Of Alzheimer Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2012-10-17 Classification: HYDROLASE Ligands: ACT, NA, 32D |
 |
New Aminoimidazoles As Bace-1 Inhibitors: From Rational Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-10-10 Classification: HYDROLASE Ligands: DMS, 1B1 |
 |
New Aminoimidazoles As Bace-1 Inhibitors: From Rational Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-10-10 Classification: HYDROLASE Ligands: ACT, 6TG |
 |
New Aminoimidazoles As Bace-1 Inhibitors: From Rational Design To Ab- Lowering In Brain
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2012-10-10 Classification: HYDROLASE Ligands: 6T6 |